Abdulla
You mean relocating manufacturing in US?
Old news surely?
3rd March
Pfizer CEO says he's prepared to shift manufacturing to the U.S. amid tariff threats |
Pfizer is leaving for USA all L,S & barrel . |
anhar,Still a poor yield. But I worth keeping them now for growth. GSK should get back to £18,in time, Even eventually £20 plus. Sold out of HLN. But GSK owe Infinity in my SIPP, and 281p in my FSA, Because I have held them going back to the 1980,s |
Gary I was criticising the term "defensive" regarding capital performance as that is how it was being used. But of course it depends when you bought. For me, that performance has been pretty poor over the time held.
Also, your math is wrong on the combined yield because the value of GSK is much higher than HLN. At present my GSK is worth roughly 3x my HLN so you can't use the simple arithmetic mean to arrive at the combined yield.
Using simplified example figures, on £9,000 of GSK yielding 4% and £3,000 HLN at 1%, the combined holding is worth £12,000. The income would be GSK £360 and HLN £30, total £390.
Thus the combined yield is 390/12,000 x 100 = 3.25%, ie. much nearer to GSK because of its heavier weighting in the pair. |
ViiV releases promising phase 2 data on potential long-acting HIV drugs |
ViiV releases promising phase 2 data on potential long-acting HIV drugs |
GSK is up a couple of quid now since I was scoffed at on 14 Nov when the price was £13.59 for suggesting that an upturn was due. Still further to go. |
https://www.bbc.co.uk/news/articles/cgkmrev6z2moMay explain the drop today, in the context of a share buy back... |
Not today. Hopefully doesn't take a dump back to 13 |
anhar, GSK is 4.14%,and HLN 1.66%. Hardly good Dividend income are they. Average of 2.9% on the Money. So they are defensive, growth and not Income Stocks ! |
Defensive? I guess it depends how long you've held this crock.
For me after aeons invested and never having traded, my combined GSK/HLN holding is up just 19% over the original old GSK cost. And it's HLN that has been the main power behind the rise, not the crockpot.
However as a long term hold income investor I'm only here for the divis and pay little attention to capital flucs. |
glad I topped up at 1300 |
defensive in times of turbulence |
Pretty much one way since Citadel went short in Jan .. must be 200p offside already |
Cheap too. |
Defensive play in the current environment |
I like this .... 20% increase in 2 months .... ;0) |
Yes, knowing them it's likely those conducting the study will be pressurised into finding one! :( |
Being Trumps government I am sure that if they look hard enough then they will find one! |
There's no link. Saved them a study |
CDC to launch study into links between autism and vaccines.Good to get this out of the way. |
Since he said it, GSK up 4.26%. Ftse down 0.66. |
Lol ! To be fair, based on his comment 'a very inexpensive stock with a 4% yield, with a lot of things going for it' he could've picked just about any FTSE-listed stock ;-) |
Oh noes, the Inverse Cramer ETF will be going short GSK then! |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
